"Management of kidney disease, hypertension (high blood pressure), kidney transplant and dialysis."

During the past decade, Washington Nephrology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Nephrology Associates" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Washington Nephrology Associates" are "Atrial Fibrillation" (1 trials), "C3 Glomerulonephritis" (1 trials), "Chronic Kidney Disease" (1 trials), "Dense Deposit Disease" (1 trials) and "End Stage Renal Disease" (1 trials). Many other conditions were trialed in "Washington Nephrology Associates" in a lesser frequency.

Most popular intervention types in "Washington Nephrology Associates" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "APL-2" (1 trials), "Kerendia (Finerenone, BAY94-8862)" (1 trials), "apixaban" (1 trials) and "warfarin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington Nephrology Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Washington Nephrology Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Washington Nephrology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Washington Nephrology Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".